Summary: Application of a topical anesthetic on the skin of the upper and lower limbs of chronic stroke and head-trauma patients induced considerable improvement in limb mobility within 30 min. We hypothesize that the augmen tation of joint mobility and reduction in muscle rigidity are the result of de sensitization of skin receptors that interact with the motor system. Physical therapy exercises performed during the effective period of the anesthetic ren dered long-lasting improvement in the patients' ability to move their upper limbs and ambulate more effectively.
During the past several years, we have been ex ploring the use of topical anesthesia as a means of rehabilitating patients with muscular hypertonicity. We pursued this approach after previous studies of normal subjects demonstrated that monosynaptic reflexes (H-reflex and Achilles tendon reflexes ATR) could be modulated by desensitization of the skin (10, 12, 13) . Compatible results have been re ported by other investigators working on related studies (2, 3, 19, 20) . In our previous studies, desen sitization of cutaneous receptors caused consider able facilitation of the H-reflex with no measurable change in the response of the ATR. A reduced sen sitivity of the muscle spindle to stretch with a si multaneous facilitation in the excitability of the o-rnotoneurons was cited as an explanation for these phenomena. Because the simultaneous effect on peripheral and spinal mechanisms suggested the use of a topical anesthetic for rehabilitation of movement in spastic patients, we investigated the immediate and long-term effects of skin desensiti zation in rehabilitation of patients affected with stroke.
METHODS
Nine patients (three women and six men) ranging in age from 21 to 84 years participated in the study. Eight were affected by stroke owing to cerebral vas cular accidents (CVA), and one had head trauma. Computed tomography (CT) scans showed central nervous system (CNS) pathology at the cerebral cortex in four patients and at the internal capsule and basal ganglia in five patients. Four of the pa tients were afflicted with right motor hemiparesis, whereas five patients had left motor hemiparesis of varying degree. The patients were chosen according to the following criteria: their CNS lesion was at least 6 months old; they no longer showed notice able improvement in physical performance, as re ported by their physician and physical therapist; they were able to ambulate with or without an as sistive device; and they retained normal superficial skin sensation in their affected limbs. Patients were not on medication when selected or throughout the study. Only seven of the nine patients were able to participate in the gait assessment segment of the experiment.
A battery of measurements was made on each patient: kinesiologic measurements of gait, video tape recordings of active movement patterns, time measurements of rapid repetitive movements (RRM) of the affected elbow and knee joints, and assessment of active and passive ranges of motion (ROM) of upper and lower limb joints. The mea surements were obtained both before and after (at intervals ~30 min) application of a topical anes thetic (20% benzocaine) to all skin areas of the af fected upper and lower limbs except the anterior tibial skin area (10, 12, 13) .
The immediate effect of the topical anesthetic on the recorded parameters was ascertained by com paring the results of the anesthetic spray tests to a second set of tests in which a placebo spray was applied on the same patients. The placebo spray was identical in all respects to the anesthetic spray except that it lacked the active ingredient. The long term effect was determined by a 2-month single blind study that combined a physical therapy pro gram with application of the topical anesthetic or a placebo spray three times a week. For the first month, patients were selected at random to receive either the placebo or the anesthetic. During the sec ond month, the procedure was alternated so that patients who received the anesthetic received the placebo and vice-versa. Thus, at the end of 2 months, each patient had received 1 month of an esthetic application and 1 month of placebo appli cation.
Five minutes after its application, the topical an esthetic induced a partial reduction in skin sensa tion to superficial touch, which was ascertained by moving cotton wool along the skin. Deep sensation of pin prick, however, was not distinguishably dif ferent from normal sensation in the contralateral limb. This minor sensory diminution was not noted when the patient was sprayed with the placebo. Pa tients also reported that their limb muscles were "looser," and that they had increased ability to control the direction and speed of limb movements after the topical anesthetic was applied.
Gait parameters were measured as the patient walked without shoes on a walkway in which a J Electromyogr Kinesiol, Vol. 1, No. 1, 1991 computer-controlled force platform was embedded. Three foot switches made of tin-foil paper were at tached to the bottom of the patient's feet. Contacts were mounted under the heel and the heads of the first and fifth metatarsals. The walkway was cov ered with a metallic surface which served as the other contact for the switches. Time histories of the gait cycle and the vertical ground reaction forces during stance phase were recorded for subsequent analysis. Data from a total of 15-25 step cycles were recorded for each patient. Four parameters were used to describe the time histories of gait cycles: swing time, double limb support time, single limb support time, and cadence. These parameters were used to calculate the symmetry factor, which mea sures the time-ratio between two successive steps, and the temporal asymmetry index, which mea sures the asymmetry between the contralateral swing and double support times. The symmetry fac tor (SF) has been proposed by Knutsson (7) For normal subjects, this value ranges from 0 to 5; for hemiplegic patients, it ranges from 10 to 30. Gait parameters were analyzed with chi-square test to establish the significance of modifications associated with the anesthetic and placebo spray. Time measurements of 10 RRM at the full joint range and performed between two fixed points were taken for the knee joint and the elbow joint. Three RRM tests were performed with rest intervals of 2 min. Movement sequences containing cycles that did not traverse the complete excursion range were discarded. The average value of the RRM tests was calculated.
RESULTS
The results are discussed in two sections. The first section, Immediate Effects, describes observa tions made 45 min after first application of the an esthetic or placebo. The second section, Long Term Effects, describes observations made at the end of the l-rnonth treatment program. In this sec ond group, measurements were made without ap plication of either anesthetic or placebo spray.
Immediate Effects
The improvement in movement parameters re sulting from application of the anesthetic is evident in Figs. 1 and 2 and Tables 1 and 2 by comparison of the results with those of the placebo . We consider a change in the value of the parameters in the direc tion toward normalcy as an improvement.
Figures 1and 2 show the improvement in the time required for 10 RRM at the elbow and knee joints for two representative patients. Figure 1 shows the results for the elbow joint of a representative pa tient. A reduction in performance time of 4 s or 20% occurred 45 min after anesthesia when the patient was initially tested. The time required to accom plish this test was decreased in varying amounts after each application of the anesthetic during the l-month period of the anesthesia program. When a t test was performed between the pretest and post test measurements, the difference was statistically significant (p < 0.05) at days 1,9, 11, 13, 16, and 30 during the 1 month of anesthesia. Figure 2 shows similar results for the knee joint of another repre sentative patient. A reduction in performance time of 1-4 s is evident 45 min after anesthesia through out the second month, when the patient was treated with anesthesia. A statistically significant (p < 0.05) reduction in performance time was recorded at days 4,9, 14, 22, and 27. These changes in performance time were not noted during the first month of treat ment with placebo. Similar results were obtained for the knee and elbow joints in all patients. No measurable changes were noted immediately after each application of the placebo. This increase in movement velocity indicates an apparent reduction of muscular rigidity. This notion is consistent with observations made in our previous work (15, 16) . Table 1 shows the gait data for the seven patients who participated in this segment of the experiment. Table 2 shows the RRM data of all nine patients. A plus sign indicates an improvement of the average values toward the normal value. A minus sign indi cates a deterioration of the average value. A blank (empty parentheses) indicates that the difference in the average values before and after application of the spray was <15%. This variability was deemed to represent the experimental error. An asterisk in dicates that the difference was statistically signifi cant at the p < 0.05 level. Generally, all parameters except TAl showed improvement 30-45 min after application of the anesthetic. The modifications noted after application of the placebo, however, were varied and considerably less pronounced. Modifications were noted in the vertical ground reaction forces. An example of the array of force vectors and the force envelope of a normal excur sion of the foot on the force plate is presented in Fig. 3a . Comparable data from a stroke patient is shown in Fig. 3b , in which the difference in the vector density and arrangement as well as the dis tortion and time elongation of the force envelope are apparent. Thirty minutes after application of the anesthetic to the affected limb (Fig. 3c) , the force diagrams assumed a more normal shape. The ab normal trial of force vectors that appeared at the end of the stance phase of the stroke patient was abolished after anesthesia.
Videotape assessment of the walking pattern pro vided qualitative evidence of a noticeable improve ment in the heel-toe walking sequence and speed and smoothness of movement. Swing phases were less jerky during gait cycle, and weight acceptance was more controlled during the stance phase. An gular displacement at hip, knee, and ankle joints during ambulation showed a substantial increase in the range of movement after anesthesia. This find ing confirmed our previous observation, which also showed the angular displacement to be increased significantly in amplitude either during performance of active movements or when the joint was moved passively (11,12,14-16). Videotape studies of the active movement pat terns of the upper limb in simulated activities of daily living (ADL) showed an increase in the range of movement after anesthesia. Active shoulder ab duction and flexion movements increased by as much as 65° in some patients, and all patients showed some increase. Active movement became smoother, and patients were able to sustain muscle contraction for a longer time through the increased range of movement, indicating improvement in con trol of the paretic limb. The improved performance was more evident in the proximal rather than the distal limb joints.
This study documents the quantified results of patients who were able to complete the arduous 2 month procedure. To date, however, we have sub jectively observed short-duration improvements in limb mobility and/or diminution of muscle rigidity in numerous other spastic patients as a consequence of a single application of the topical anesthetic. These include 12 additional CV A patients, 5 Parkin son's disease patients, 8 cerebral palsy children (ranging in age from 10 months to 16 years),and 3 patients with spinal cord injuries.
Long-Term Effects
When the topical anesthetic was applied before every physical therapy session, it was easier for the 
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Modification in the parameter was toward normal standards ( +), a shift away from normal ( -), and no measurable change patient and therapist to conduct the exercise pro gram, apparently owing to the decreased muscular rigidity. Therapists reported a decrease in the stiff ness of the affected muscles during passive stretch with a decreased abnomal active-movement syn ergy in most patients. The improved performance of active movement with reduction of pathologic syn ergy augmented the functional capability of the pa tients. The compound effect of reduced muscular rigidity and increased motor output is supported by our studies on the Hand ATRs in the same patients (15, 16) and by our previous studies of normal sub jects (10, 11) .
At the end of the l-month period of the topical Figure 2 shows similar results in another patient tested for the time performance of 10 RRM at the knee joint. The patient completed the 10 RRM at the knee joint in 17 s at the beginning of the study, whereas at the end of 1 month of an esthetic treatment he required only 10 s to complete the task. This shows a statistically significant (p < 0.001) long-term reduction in the time required for completion of 10 RRM. A t test performed between the beginning and end of the month of the placebo showed no statistically significant difference in the measured parameter. One might argue that the changes in movemment performance shown in Figs. 1 and 2 resulted from waxing and waning of the spasticity. Although this is an inherent problem in patients affected with spasticity, it did not affect our results dramatically for two reasons: First, each patient was tested for the immediate (short-term) effect during the same recording session when no extraneous factors influ enced the patient's muscle tone. Second, the long term effect was indicated by the trend in movement performance during the month of anesthesia or pla cebo treatments. Figures 1 and 2 show that such possible waxing and waning of spasticity was not apparent during the month of placebo application. On the contrary, variability in movement perfor mance appeared to be relatively smaller during the month of placebo application as compared with the month of anesthetic application. Therefore, the cu mulative long-term reduction of movement perfor mance time during the first month appears to be due to application of the topical anesthetic and not to other extraneous factors.
The gait parameters for all patients ( Table 1 ) in dicate that almost every parameter of the temporal components of the gait cycle showed a statistically significant (p < 0.05) shift toward normal standards.
In the sample subject (Fig. 1) , single limb support time and cadence improved by 35%. The vertical ground reaction force assumed a more normal en velope. The abnormal trial of force vectors which appeared at the end of the stance phase of the stroke patient diminished considerably, indicating a decreased shuffling of the foot during ambulation. These results were also noted in the force-time curve. Table 2 shows that this outcome was typical for eight of nine patients. A videotape study of upper and lower limb movement at the end of the treat ment program demonstrated improvement in active ROM, movement speed and synergy, and heel-toe walking pattern during ambulation, and a near ab sence of foot shuffling during swing phase. These improvements in movement performance were re flected in the functional ADL as reported by the patients.
DISCUSSION
The modification of the movement parameters noted within 30-45 min of application of the topical anesthetic suggests that excitation and/or inhibition of the a and 't systems were altered. The o-moto neurons increased in excitability (resulting in in creased motor output) and simultaneously the v-motoneurons decreased in excitability (resulting in decreased muscular rigidity). These findings are consistent with our previous work on the Hand ATR in normal human subjects (10, 13) and with the work of other investigators in animals (2, 3, 19, 20) . A similar explanation was offered to account for the reduction of physiologic action tremors in normal subjects and pathologic clonus in spinal cord injury patients after desensitization of the skin by topical anesthesia (9) . Other recent work of ours suggests that removal of excitatory drive from the skin by application of topical anesthetic would favor in creased inhibition in the spinal cord (8) . This behav ior could cause the previously suggested inhibition of «-motoneurons (13) and tonic reflexes (17) . Because the improvements in the movement pat terns and reduction in rigidity were not evident when the placebo spray was used, we inferred that the modifications in motor output are induced by the anesthetic agent. The effect may occur in at least two possible ways. First, it may be mediated by the direct effect on a-and "(-motoneurons of the anesthetic that is absorbed into the blood stream. Such a possibility is unlikely. In a companion study, we detected no traces of benzocaine in the systemic circulation after extensive application of topical an esthetic to the skin of the upper and lower limbs. Second, it may be mediated by the desensitizing effect on the cutaneous receptors. This latter expla nation implies that the affected cutaneous receptors (either receptor adaptation or reduced activation) either generate spontaneous activity or are stimu lated to discharge by the motion of the skin as the limb begins to move. Mechanoreceptors with group III or IV fibers have been shown to have both mo dalities of behavior (4) (5) (6) 18) and may be considered suitable candidates for either signaling or inducing the alterations in motor output, although other skin receptors may participate. Therefore, the reduced activity of the cutaneous receptors would induce a slow-acting accommodation in the peripheral mo tor system. Wolf and Mirkwitz reported no significant changes in the H-reflex or the ATR of stroke pa tients after benzocaine anesthetic. The difference in results in the study of Wolf and Mirkwitz (21) and our current studies may be due to different meth odology as well as criteria applied to patient selec tion.
The long-term effect on the motor system ob served in this study is a reflection of the potential overt plasticity of the eNS. The observed move ment improvement is most likely due to the physical exercise that the patients were able to perform as a result of application of the topical anesthetic. The effects of the anesthetic lasted ~ 3 h and peaked 30-45 min after application (10) . When desensitiza tion subsided, the movement pattern of the patients reverted to the preanesthetic state. Thus, applica tion of the anesthetic was used to generate a time window during which patients were able to perform physical therapy exercise they could not otherwise perform. We believe that this augmented therapy induced the long-term effects. Although all the pa tients were chosen from a population that was no longer benefiting from its current physical therapy program, we were able to augment the limb move ment range of all of them. In some patients, this augmented movement range gave them freedom to perform basic ADL such as eating, grooming, and hygiene maintenance on their own.
